ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Phytomodulatory latex proteins improve blood homeostasis in diabetic mice with disseminated bacterial infection.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Blood rheology and hematology are essential factors in vascular health in diabetic patients. Additionally, in patients with systemic infections, blood characteristics change rapidly, increasing cardiovascular risk. The present study examined the role of immunomodulatory proteins from Calotropis procera latex (CpLP) on blood homeostasis in diabetic mice with disseminated bacterial infection. A virulent strain of Salmonella was used as the infection model. Employing the Bingham fluid model, it was determined that CpLP therapy diminished blood yield stress by 75% and decreased the flow behavior index by 26% in diabetic mice. CpLP also boosted red blood cells (RBCs) count by 1.1%, white blood cells (WBCs) count by 63.7%, and platelets by 54% compared to untreated diabetes controls. These improvements were statistically significant (p < 0.05), confirming the anti-inflammatory response and increased oxygen-carrying capacity of CpLP-treated blood. Overall, the data indicates that CpLP enhances blood fluidity and regulates hematological parameters in hyperglycemia, presenting potential therapeutic implications for the management of diabetic vascular problems. This work provides novel insights into plant latex proteins as prospective medicines in the therapy of diabetes-related cardiovascular problems in infected patients.
Indexed as
Identifiers
40839004What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.